Study Finds Opto-Acoustic Imaging During Neoadjuvant Therapy Correlates to Pathologic Response
Study evaluates feasibility of leveraging Seno’s Imagio® System to detect response earlier during breast cancer therapy. [San Antonio, TX – December 8, 2023] A limited feasibility study presented at this year’s San Antonio Breast Cancer Symposium (SABCS) found that Seno Medical’s Imagio® Breast Imaging System using opto-acoustic/ultrasound (OA/US) shows promise in detecting vessel and oxygenation changes preceding tumor […]
Study Finds Opto-Acoustic Imaging Provides Significant Cost Benefits When Compared to Ultrasound Alone in Evaluation of Breast Lesions
Imagio® System’s unique hybrid modality helps doctors better characterize suspicious breast lesions to avoid unnecessary invasive biopsies and improve patient care. [San Antonio, TX – November 30, 2023] A study presented at RSNA and published in Academic Radiology has found that Seno Medical’s Imagio® Breast Imaging System with opto-acoustic ultrasound (OA/US) imaging is more cost effective when compared to […]
Device standards bring a new light to clinical imaging
spie.org
Alex Hamlow Joins Seno Medical as Chief Revenue Officer
[SAN ANTONIO, TX – SEPTEMBER 22, 2023] Alex Hamlow has joined Seno Medical Instruments, Inc. as Chief Revenue Officer. Seno Medical is the leader in improving the process of diagnosing breast cancer and the pioneer of the Imagio® Breast Imaging System with opto-acoustic/ultrasound (OA/US) imaging technology. Hamlow has over 20 years of experience in the healthcare […]
Seno Medical Adds Agnes Berzsenyi to Board of Directors
[SAN ANTONIO, TX – SEPTEMBER 14, 2023] Seno Medical Instruments, Inc., the leader in improving the process of diagnosing breast cancer and the pioneer of the Imagio® Breast Imaging System with opto-acoustic/ultrasound (OA/US) imaging technology, has added Agnes Berzsenyi to its Board of Directors, effective immediately. Ms Berzsenyi spent over 27 years at General Electric, where […]
Supplemental Optoacoustic Imaging of Breast Masses: A Cost-Effective Analysis
academicradiology.org
Seno Medical’s Photoacoustic Imaging Modality Added to DICOM® Standards Update
Seno’s Imagio® System Uses Photoacoustic (Opto-acoustic) and Ultrasound Imaging to help doctors better characterize suspicious breast lesions to avoid unnecessary invasive biopsies and improve patient care. [San Antonio, TX – July 20, 2023] Seno Medical’s technology platform for the Imagio® Breast Imaging System – which includes Photoacoustic imaging – has been added to the Digital Imaging and Communications […]
Seno Medical’s SenoGram® Decision Support Tool Named Winner in 2023 Artificial Intelligence Excellence Awards
[SAN ANTONIO, TX – March 23, 2023] The Artificial Intelligence Excellence Awards program has selected Seno Medical’s AI platform, SenoGram® — exclusively available in conjunction with the company’s Imagio® Breast Imaging System — as a winner in its first annual program. SenoGram® is an artificial intelligence (AI) decision-support tool that helps physicians interpret new images from the Imagio® System. The SenoGram®, […]
New technology improves the utility of breast ultrasound
radiologytoday.net
Seno Medical Inks Exclusive Agreement with Genetik, Inc. as Distributor for Imagio® Breast Imaging System in Southeast Asia
(SAN ANTONIO, TX – January 13, 2023) Seno Medical has entered into an exclusive distributor agreement with Genetik, Inc., to market, sell and service the company’s groundbreaking Imagio® Opto-Acoustic/Ultrasound (OA/US) Breast Imaging System. This distributor agreement – a first for Seno – will enable Genetik to regionally distribute the Imagio® System in Singapore, where the distributor is […]